Trials / Sponsors / Nalo Therapeutics Inc.
Nalo Therapeutics Inc.
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Study of NX-019 in Patients with Advanced, Epidermal Growth Factor Receptor (EGFR) Mutant Cancer EGFR Mutation-Related Tumors | Phase 1 | 2022-10-05 |